Analyst: NxStage poised to tap $1 billion dialysis market - Mass Device PDF Print
Mass Device
NxStage Medical is poised to drive double-digit annual sales growth as it boosts its 1 percent share of the dialysis market, according to Leerink Swann analyst Danielle Antalffy. NxStage Medical Inc. (NSDQ:NXTM) is poised to take a $1 billion bite out

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.